SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-19-000143
Filing Date
2019-10-17
Accepted
2019-10-17 17:41:11
Documents
1
Period of Report
2019-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157134842257231.html 4  
1 FORM 4 wf-form4_157134842257231.xml 4 5650
  Complete submission text file 0000920465-19-000143.txt   6892
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
MULROY DENNIS (Reporting) CIK: 0001276840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 191156187